February 11, 2026 — Leads & Copy — AbCellera (Nasdaq: ABCL) announced today that it will present at several investor conferences in the coming months.
The presentations include:
TD Cowen 46th Annual Health Care Conference, March 4, 2026
KeyBanc Capital Markets Healthcare Forum, March 17, 2026
Bloom Burton & Co. Healthcare Investor Conference, April 21-22, 2026
Live audio webcasts of each presentation will be accessible through a link posted on AbCellera’s Investor Relations website closer to the presentation dates. Replays will also be available through the same link following each presentation.
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in endocrinology, women’s health, immunology, and oncology.
Source: AbCellera
